Group A streptococcal vaccines

Infectious Disease Clinics of North America

Volumn 13, Issue 1, 1999, Pages 227-243

  Dale, J B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE;

BACTERIAL IMMUNITY; IMMUNE RESPONSE; PATHOGENESIS; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

EID: 0032910260     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70052-0     Document Type: Article

References (29)

1. R.W. Baird M.S. Bronze W. Kraus Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium J Immunol 146 1991 3132
2. E.H. Beachey M.S. Bronze J.B. Dale Protective and autoimmune epitopes of streptococcal M proteins Vaccine 6 1988 192
3. E.H. Beachey G.H. Stollerman R.H. Johnson Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein J Exp Med 150 1979 862
4. D. Bessen V.A. Fischetti Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci Infect Immun 56 1988 2666
5. A.L. Bisno The concept of rheumatogenic and nonrheumatogenic group A streptococci Reed S.E. Zabriskie J.B. Streptococcal Disease and the Immune Response 1980 Academic Press New York 789
6. M.S. Bronze H.S. Courtney J.B. Dale Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses J Immunol 148 1992 888
7. M.S. Bronze J.B. Dale Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain J Immunol 151 1993 2820
8. H.S. Courtney J.B. Dale D.L. Hasty Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and Hep-2 tissue culture cells Infect Immun 64 1996 2415
9. J.B. Dale Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments Vaccine, 17 1999 193
10. J.B. Dale E.H. Beachey Multiple heart-cross-reactive epitopes of streptococcal M proteins J Exp Med 161 1985 113
11. J.B. Dale E.H. Beachey Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart J Exp Med 156 1982 1165
12. J.B. Dale E.C. Chiang Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections J Infect Dis 171 1995 1038
13. J.B. Dale E.Y. Chiang J.W. Lederer Recombinant tetravalent group A streptococcal M protein vaccine J Immunol 151 1993 2188
14. J.B. Dale M. Simmons E.C. Chiang E.Y. Chiang Recombinant, octavalent group A streptococcal M protein vaccine Vaccine 14 1996 944
15. J.B. Dale R.G. Washburn M.B. Marques M.R. Wessels Hyaluronate capsule and surface M protein in resistance to phagocytosis of group streptococcal Infect Immun 64 1996 1495
16. V.A. Fischetti Streptococcal M protein: Molecular design and biological behavior Clin Microbiol Rev 2 1989 285
17. V.A. Fischetti R.D. Horstman V. Pancholi Location of the complement factor H binding site on streptococcal M protein Infect Immun 63 1995 149
18. D.L. Hasty I. Ofek H.S. Courtney R.J. Doyle Multiple adhesins of streptococci Infect Immun 60 1992 2147
19. Y. Ji B. Carlson A. Kondagunta P.P. Cleary Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus Infect Immun 65 1997 2080
20. D.R. Johnson D.L. Stevens E.L. Kaplan Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis J Infect Dis 166 1992 374
21. V. Kapur J.T. Maffei R.S. Greer Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci Microb Pathog 16 1994 443
22. D.L. Kiska B. Thiede J. Caracciolo Invasive group A streptococcal infections in North Carolina: Epidemiology, clinical features, and genetic and serotype analysis of causative organisms J Infect Dis 176 1997 992
23. M. Kotb Bacterial pyrogenic exotoxins as superantigens Clin Microbiol Rev 8 1995 411
24. R.C. Lancefield Persistence of type-specific antibodies in man following infection with group A streptococci J Exp Med 110 1959 271
25. R.C. Lancefield Current knowledge of the type specific M antigens of group A streptococci J Immunol 89 1962 307
26. S. Lukomski S. Sreevatsan C. Amberg Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains J Clin Invest 99 1997 2574
27. K. Nakashima S. Ichiyama Y. Iinuma A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints Clin Infect Dis 25 1997 260
28. L.G. Salvadori M.S. Blake M. McCarty Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies J Infect Dis 171 1995 593
29. E. Whitnack E.H. Beachey Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci J Clin Invest 69 1982 1042